For example, enhanced autophagy could lessen the BCR-ABL-independent resistance of chronic myeloid leukemia cells to ponatinib (Kayabasi et al., 2017). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.